Literature DB >> 11166616

Clinical spectrum of restrictive cardiomyopathy in children.

S C Chen1, I C Balfour, S Jureidini.   

Abstract

We reviewed the clinical spectrum and possible prognostic factors in 14 children with restrictive cardiomyopathy. The patients were not homogeneous in clinical presentation or morphology. The mortality rate was high: 21.4% at 1 year and 50% at 2 years after presentation. Younger patients with respiratory symptoms, thromboembolism, increased cardiothoracic ratio on chest radiogram or patients with endocardial fibroelastosis appear to have a worse prognosis and orthotopic cardiac transplantation may be indicated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166616     DOI: 10.1016/s1053-2498(00)00162-5

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  15 in total

Review 1.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

2.  Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children.

Authors:  M J Fenton; H Chubb; A M McMahon; P Rees; M J Elliott; M Burch
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 3.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach.

Authors:  Jose Renato Pinto; Shi Wei Yang; Marc-Phillip Hitz; Michelle S Parvatiyar; Michelle A Jones; Jingsheng Liang; Victor Kokta; Mario Talajic; Nicolas Tremblay; Michelle Jaeggi; Gregor Andelfinger; James D Potter
Journal:  J Biol Chem       Date:  2011-04-18       Impact factor: 5.157

5.  Idiopathic restrictive cardiomyopathy in children.

Authors:  L M Russo; S A Webber
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

6.  Persistent pulmonary hypertension late after neonatal aortic valvotomy: a consequence of an expanded surgical cohort.

Authors:  M Burch; L Kaufman; N Archer; I Sullivan
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 7.  Cardiac troponin mutations and restrictive cardiomyopathy.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; David Dweck; James D Potter
Journal:  J Biomed Biotechnol       Date:  2010-06-08

8.  Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations.

Authors:  Yuejin Li; Lei Zhang; Pierre-Yves Jean-Charles; Changlong Nan; Guozhen Chen; Jie Tian; J-P Jin; Ira J Gelb; Xupei Huang
Journal:  J Mol Cell Cardiol       Date:  2013-06-26       Impact factor: 5.000

Review 9.  Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.

Authors:  Steven E Lipshultz; Thomas R Cochran; David A Briston; Stefanie R Brown; Peter J Sambatakos; Tracie L Miller; Adriana A Carrillo; Liat Corcia; Janine E Sanchez; Melissa B Diamond; Michael Freundlich; Danielle Harake; Tamara Gayle; William G Harmon; Paolo G Rusconi; Satinder K Sandhu; James D Wilkinson
Journal:  Future Cardiol       Date:  2013-11

10.  Insights into restrictive cardiomyopathy from clinical and animal studies.

Authors:  Pierre-Yves Jean-Charles; Yue-Jin Li; Chang-Long Nan; Xu-Pei Huang
Journal:  J Geriatr Cardiol       Date:  2011-09       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.